References
1. Jishu Wei, Shibo Lin, Cong Wang, Junli Wu, Zhuyin Qian, Cuncai Dai, et al. Glucagonoma syndrome: A case report. Oncol Lett. 2015;10 (2):1113-6
2. Teixeira RC, Nico MMS, Ghideti AC. Necrolytic migratory erythema associated with glucagonoma: a report of 2 cases. Clinics. 2008;63(2):267‑70.
3. Beek Á PV, Haas ERMD, Vloten WAV, Lips CJM, Roijers JFM, Dijk MRC. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;151:531-7.
4. Tolliver S, Graham J, Kaffenberger BH. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema. Int J Dermatol. 2018;57(6):642‑5.
5. Khoshnia M, Norouzi A, Hosseininejad S-M, Hosseininejad F-S. Glucagonoma Neuroendocrine Tumor with the Clue of Necrolytic Migratory Erythematous Rash: A Case Report. 2018;2(1):2292-5.
6. Wu S, Bai J, Xu J, Ma Q, Wu Z. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor. World J Surg Oncol. 2014;12(1):220.
7. Halvorson SAC, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M, et al. Putting the Pieces Together: Necrolytic Migratory Erythema and the Glucagonoma Syndrome. J Gen Intern Med. 2013;28(11):1525‑9.
8. Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A. Necrolytic Migratory Erythema as the First Manifestation of Glucagonoma. Case Rep Surg.2012.
9. Han X, Wang D, Kuang T, Rong Y, Lou W. Glucagonoma syndrome: report of one case. Transl Gastro enterol Hepatol. 2016;1.
10. Cruz-Bautista I, Lerman I, Perez-Enriquez B, Padilla LS, Torres CL, Lopez A, et al. Diagnostic challenge of glucagonoma: case report and literature review. Endocr Pract. 2006;12(4):422‑6.
11. Sheng Fang, Shuang Li, Tao Cai. Glucagonoma syndrome: a case report with focus on skin disorders. Onco Targets Ther. 2014;7:1449–53.
12. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients: Medicine (Baltimore).1996;75(2):53‑63.
13. el Darouty M, Abu el Ela M. Necrolytic migratory erythema without glucagonoma in patients with liver disease. J Am Acad Dermatol. 1996;34(6):1092‑3.
14. Dinc B, Sahin C. Metastatic glucagonoma. Eurasian J Med. 2009;41(1):70.
15. Feldmann R, Wahl S, Steiner A. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema. J Eur Acad Dermatol Venereol JEADV. 2018;32(8):e306‑7.
16. Tremblay C, Marcil I. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition. J Cutan Med Surg. 2017;21(6):559-61.
17. Cardoso D, Cardoso A, Filho FC. Pancreatic glucagonoma associated with necrolytic migratory erythema: case report and clinical review. Eur J Cancer. 2017;72:S151.